Manufacturing & Quality
Industrial Manufacturing Standards
Manufacturing sits within the group's operating companies. What the parent sets is the standard they are held to: strict adherence to Master Formula Records, comprehensive process validation, and continuous technical review.
Research
Clinical R&D and Formulation
Development capability sits within the group's operating companies, funded by the parent. Granulation parameters and active pharmaceutical ingredient stability are tested rigorously, because therapeutic efficacy and shelf life in the climates these products ship to are decided at that stage rather than at release.
Quality systems
Quality is built in, not inspected in afterwards.
Our quality framework is proactive — designed to identify and mitigate risk before it becomes a quality event — governed through defined procedures, controlled documentation and continuous monitoring.
- Documentation control and data integrity
- Standard Operating Procedures
- Good Documentation Practices
- Change control
- Deviation handling and root cause analysis
- Corrective and preventive action (CAPA)
- Training and competency management
- Vendor qualification and oversight
- Audit management and continuous improvement
Manufacturing oversight
Corporate quality works alongside partner sites, vendors and laboratories so that every product is manufactured, packaged, stored and distributed under controlled and compliant conditions.
Pharmacovigilance
Post-marketing safety monitoring, adverse event handling, and the reporting obligations that attach in each territory where a product is registered.
Research priorities
Where development effort goes.
Differentiated formulations
Products that solve a delivery, stability or compliance problem the market has not solved well.
Pipeline development
A staged development portfolio rather than opportunistic single products.
Academic collaboration
Working with institutions to shorten the path from research to a registrable product.
Clinical validation
Evidence generated to the standard each destination regulator expects.
Compliance
Regulatory Dossier Readiness
Cross-border regulation rewards preparation over reaction. Commercial and regulatory dossiers for Rest of World markets are prepared at group level and held against each destination regulator's requirements, so a registration can be filed when a market opens rather than started from scratch once it has.